Aegon to become Transamerica and relocate to the U.S. The stock dives.
By Steve Goldstein
Aegon to move to the U.S. East Coast
Aegon is moving to the U.S., but not San Francisco, home to the Transamerica Pyramid skyscraper.
The insurer Aegon on Wednesday said it's relocating its headquarters from the Netherlands to the U.S. and renaming itself Transamerica, as part of its ambition to become a leading U.S. life insurance and retirement company.
It didn't identify which city it will locate its headquarters in, but it won't be San Francisco despite the skyscraper there that bears Transamerica's name. Instead, it'll be "somewhere on the East Coast," while Delaware will be the legal domicile.
The decision, announced at a London capital markets event, will need shareholder approval, and Aegon is planning a vote for the fourth quarter of next year. Vereniging Aegon, Aegon's largest shareholder with a 17% stake according to FactSet, "considers the decision to relocate Aegon Ltd. to the U.S. an important and positive step for Aegon" though it will still review any proposals.
Transamerica already represents about 70% of its operations. The insurer said it will start reporting its results under U.S. GAAP, rather than international, accounting rules starting in 2027. It already has stock market listings on the New York Stock Exchange and Euronext, but it will make the NYSE the primary one in a bid to get included in U.S.-focused indices.
The relocation in total will cost EUR350 million before tax, spread between 2025 and 2028.
Aegon also said it may sell its U.K. arm, announced a EUR400 million stock buyback and a $10 billion reinsurance transaction.
The stock (NL:AGN) (AEG) dived 8% in Amsterdam trade, with investors focusing on the company's capital generation and free cash flow targets, which were about 5% to 8% below expectations according to UBS calculations.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-10-25 0444ET
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
